Background: Therapeutic thiol administration has been shown to have great potential in a variety of pathological conditions associated with oxidative stress. In the present study, the free radical scavenging effects against superoxide anion (O 2 -) and hydroxyl ( . OH) radicals of captopril were compared with those of cysteamine and mercaptoethanol. Methods: The O 2 -and . OH were generated in vitro. Deoxyribose (DR) was used as a detector of . OH radicals. The degradation of DR was measured in terms of the formation of thiobarbituric acid reactive substances, which were quantified spectrophotometrically. Superoxide anion radicals were generated photochemically and O 2 --produced nitro-blue tetrazolium (NBT) reduction was measured. Results: Using two distinct . OH generating systems, the DR test showed that in the absence of the chelator diethylene triamine pentaacetic acid (DTPA) cysteamine was much more potent inhibitor of the formation of thiobarbituric acid reactive substances (TBARs) than captopril and mercaptoethanol, and that in the presence of DTPA captopril and mercaptoethanol decreased the TBARs formation in presence of H 2 O 2 better than cysteamine. Captopril in concentration of 9.34 mM and cysteamine in concentration of 1.21 mM inhibited the O 2 -provoked NBT reduction by 50%. Mercaptoethanol up to 10 mM did not manifest an inhibitory effect. Conclusions: Captopril and mercaptoethanol are potent free radical scavengers, reacting rapidly with . OH, whereas cysteamine acts preferentially as a chelator of iron and in this way prevents the formation of . OH.
Introduction
Captopril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the treatment of hypertension and congestive heart failure. It has been observed that the application of captopril in various diseases related to free radical damage ameliorates the oxidative stress provoked injury. In the "stunned" canine myocardium, a phenomenon associated with the production of oxygen radicals, the administration of this ACE inhibitor improved recovery of contractile function [1] . In transplanted lungs studied after an extended cold preservation period, the use of captopril in the preservation solution reduced ischemia-reperfusion injury (free radicals are involved in the pathology of ischemia/reperfusion injury) [2] .
The mechanisms by which captopril is protective remain elusive. It might be assumed that the beneficial response of captopril against heart and peripheral vascular disease could be complemented by its action as a free radical scavenger [3] . Captopril contains a sulphydryl (-SH) group that accounts for its electron-donating character, and therefore, a potential antioxidant effect against free radicals could be hypothesized. In the organism, not all captopril is bound to ACE. Much of it is carried as adsorbed captopril or as disulphydes with endogenous sulphydril-containing compounds such as glutathione and plasma proteins [4] . In this way, it can serve as the depot of the drug and could function as recyclable antioxidant agent [5] .
Data describing the pro/antioxidant capacity of mercaptoethanol and cysteamine, two other sulphydril-containing compounds, are scanty. According to the literature, they could also exhibit antioxidant activity. Gupta et al. [6] demonstrated that the addition of beta-mercaptoethanol to vitrification and culture medium partially annihilated the ROS activity of vitrified-warmed oocytes. Cysteamine confers protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced oxidative toxicity in the dopaminergic neurons in a mouse model for Parkinson's disease [7] .
Thiol compounds could act as antioxidants through a variety of mechanisms, including their roles as components of the general thiol/disulfide redox buffer, as metal chelators, as radical quenchers, as substrates for specific redox reactions (glutathione in particular), and as specific reductants of individual protein disulfide bonds (thioredoxin). However, although the presence of a sulfhydryl group suggests antioxidant properties, some thiol-containing compounds can exhibit pro-oxidant activity. Under certain circumstances, thiols cause apoptosis, and the hypothesis that thiols cause apoptosis via production of hydrogen peroxide (H 2 O 2 ) during thiol oxidation raised. HL-60 cells treated with 2 mM dithiothreitol begin to show generation of ROS within 5 min of its addition; the ROS generation appears to be maximal at 15 min [8] . Therefore, thiols are able to act as antioxidants by reacting with ROS and can be prooxidants producing ROS-at least in vitro-and in particular, H 2 O 2 via copper-catalyzed thiol oxidation and . OH via the Fenton reaction [9, 10] . ROS have a dual role in cellular function: on one hand, they are hazardous for living organisms and damage all cellular constituents, but on other hand, they play an important role as regulatory mediators in signalling processes, the determination of biological substances, and in particular for drugs, their pro/antioxidant capacity is essential.
For the present study we chose captopril, a clinically applied drug, to compare it with cysteamine and mercaptoethanol; all are sulfhydryl-containing substances with indications for providing an antioxidant effect. Based on the mechanism of antioxidant action, the free radical scavenging and/or metal chelating effects of those substances were examined against superoxide anion (O 2 -) and hydroxyl radical (OH.) generated in vitro.
Materials and methods

Materials
Captopril ((2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid), cysteamine (2-aminoethanethiol) and mercaptoethanol (2-Hydroxy-1-ethanethiol), as well as deoxyribose (DR) and catalase were purchased from Sigma Chemical Co. Nitro-blue tetrazolium (NBT) was purchased from Serva; diethylene triamine pentaacetic acid (DTPA), ethylene diamine tetraacetic acid (EDTA), H 2 O 2 , methionine and riboflavin -from Merck. All other reagents were analytical grade; all solutions were prepared with de-ionized water.
OH-generating system
The degradation of DR (a detector of . OH radicals) was measured in terms of formation of thiobarbituric acid reactive substances (TBARs), according to the method of Gutteridge [11] . The TBARs were quantified spectrophotometrically. Hydroxyl radicals ( . OH) were generated in a system containing either (1) 10 mM potassium phosphate buffer, pH 7.4; 0.1 mM FeSO4 and 2 mM deoxyribose (DR) or (2) 10 mM potassium phosphate buffer, pH 7.4; 0.1 mM DTPA-Fe 2 + (the DTPA-Fe2+ complex was prepared according to Cohen [12] ), 0.5 mM H 2 O 2 and 2 mM deoxyribose (DR). After 30-min incubation at 37°C in the presence of increasing concentrations of the tested drugs, the reactions were stopped by the addition of catalase (20 µg/ml). After addition of 0.2 ml 2.8% trichloroacetic acid, 0.1 ml 5 N HCl and 0,2 ml thiobarbituric acid (2% w/v in 50 mM NaOH), the samples were heated at 100°C for 15 min to develop color. After cooling, the absorbance was read at 532 nm against a blank sample (without drug); A 600 was considered to be a non-specific base-line drift and was subtracted from A 532 .
O 2 --generating system
Superoxide anion radicals (O 2 -) were generated photochemically in a medium containing 50 mM potassium phosphate buffer, pH 7.8; 1.17x10-6 M riboflavin; 0.2 mM methionine; 2x10-5 M KCN and 5.6x10-5 M nitroblue tetrazolium (NBT); and 1x10-4 M EDTA. The O 2 --produced NBT reduction was measured in the presence of increasing concentrations of the tested drugs after a 7-min lighting of the samples, according to the method of Beauchamp & Fridovich [13] .
Statistical analysis
Data were reported as mean ± SEM. The results were statistically analysed by two-way ANOVA (Bonferroni post-tests), P < 0.001 being accepted as the minimum level of statistical significance for the differences in population mean values. Figure 1 shows the percentage inhibition of TBARs formation by increasing doses of captopril, cysteamine and mercaptoethanol. The inhibition increased with the concentration of the drugs in both . OH generating systems. In absence of the chelator, cysteamine was a much more potent inhibitor of the formation of TBARs than were captopril and mercaptoethanol ( Figure 1A ). When Fe 2 + ions of the reaction medium were chelated to DTPA, the inhibitory potential of cysteamine decreased and both captopril and mercaptoethanol demonstrated a stronger effect than that of cysteamine ( Figure 1B ). Captopril and mercaptoethanol decreased the formation of TBARs in presence of H 2 O 2 to an almost equal extent. The tested drugs dose-dependently inhibited O 2 --provoked NBT-reduction. Captopril in the highest concentration tested (10 mM) inhibited the O 2 --provoked NBT reduction by about 60%, whereas cysteamine, even at the lowest concentration tested (1 mM), achieved more than 40% inhibition (Table 1) . Mercaptoethanol up to 10 mM did not exhibit any inhibitory effect.
Results
Discussion
In the present study, we used two distinct . OH generating systems with DR as a detector molecule. The first deoxyribose test evaluates the possibility of DR to bind iron ions. Bound on this detector molecule, the latter could undergo autoxidation with a production of superoxide anion radicals (O 2 -), which dismutate to H 2 detector molecule by transferring the damage to itself. The protection depends on the concentration of scavenger with respect to the detector molecule and on the scavenger's second-order rate constant of reaction with . OH. Using this method for generation of . OH, we found that (1) the inhibition was dose dependent and (2) cysteamine was a potent inhibitor of TBARs formation ( Figure 1A) . It seems that cysteamine acts preferentially as a chelator of iron rather than as a radical scavenger, because when Fe 2 + is chelated to DTPA (see below), the inhibitory potential of this drug decreases and shows the weakest result compared with captopril and mercaptoethanol ( Figure 1B) .
Hydroxyl radicals may also be generated in vitro by exposing the detector molecule (DR in our experiments) to DTPA-Fe 2 + in the presence of H 2 O 2 . Chelation of the metal ion will prevent its association with DR, and the generated . OH will have equal access to all components of the reaction mixture: DTPA-Fe 2 + + H 2 O 2 -> DTPA-Fe 3 + + OH -+ . OH Under these conditions, we have found that captopril and mercaptoethanol decreased the TBARs formation in presence of H 2 O 2 better than cysteamine, which suggests that they possess predominantly free radical scavenging activity ( Figure 1B) .
We also investigated the scavenging effects of captopril, mercaptoethanol and cysteamine against O 2 -. Our results indicated that both captopril and cysteamine can dosedependently inhibit the O 2 -provoked NBT reduction and achieve a 50% reduction at concentrations of 9.34 mM and 1.21 mM, respectively (Table 1) . Indeed, these concentrations are very high, in particular for captopril, given that the peak blood concentrations of captopril are around 0.5 µM in patients with heart failure after peroral drug administration of 25 mg [14] . The superoxide radical-scavenging activity of captopril has been studied by several investigators, and the results have been contradictory. Some reported a high superoxide scavenging activity, whereas others found that captopril removed superoxide inefficiently. Chopra et al. [5] , using the technique described by Misra and Fridovich [15] , demonstrated that captopril specifically scavenges O 2 -. On the other hand, Winterbourn & Metodiewa [16] as well as Kukreja et al. [17] , using a number of superoxide-generating systems such as xanthine-xanthine oxidase, phorbol myristate acetate-activated neutrophils, auto-oxidizing dihydroxyfumarate, and auto-oxidation of epinephrine to adrenochrome, asserted that captopril does not scavenge superoxide anion. However, in the organism, the compounds could have diverse lines of activity, and the effect could be different from that observed in chemical systems.
Captopril has been reported to inhibit neutrophil NADPH oxidase [18] , which decreases leukocyte pro-oxidant generation. Upon activation of proinflammatory mediators, the membrane-associated NADPH oxidase reduces molecular oxygen by one electron to yield the superoxide anion radicals, which push the ROS generating machine, yielding H 2 O 2 (by spontaneous dismutase) or hydroxyl radicals (by interaction with H 2 O 2 in the presence of trace amounts of metal). In reperfusion-induced myocardial dysfunction, it appears that captopril acted as a nonspecific antioxidant, probably by reducing an intermediate in the complex oxidation of epinephrine to adrenochrome [17] . In its turn, cysteamine is constitutively produced by all tissues in human and animal body as part of the coenzyme A (an acyl carrier group required for many metabolic processes) catabolic pathway [19] . Recent work has shown that many tissues are capable of converting cysteamine to hypotaurine and subsequently to taurine in vivo [20] . Cysteamine seems to be the main source of taurine, the second most abundant amino acid in the brain, with membrane-stabilizing and antioxidant properties [21] . Oral administration of cysteamine to mice significantly increased levels of the antioxidant enzyme superoxide dismutase (SOD) in plasma, liver and brain, and obviously up-regulated the activity of glutathione peroxidase (GSH-Px) in plasma [22] . Also, β-mercaptoethanol, in addition to its direct antioxidant activity, can lead to up-regulation of glutathione synthesis [23] . In accordance with our results, there are abundant examples of the free radical scavenger activity of mercaptoethanol in the literature. In this study, we compared the captopril antioxidant activity with those of cysteamine and mercaptoethanol not only among them in the same medium, but also in regard to two different ROS (hydroxyl radicals and superoxide anion radicals). We hope that our study will contribute to the knowledge of these thiolcontaining substances. Although the present results cannot be directly extrapolated to the clinical setting, they contribute to an understanding of the mechanism by which these compounds act as antioxidants, and further, suggest that by their use, lowering of free radical concentration may be possible in both laboratory and clinical practice.
Conclusion
According to our results, captopril and mercaptoethanol are potent free radical scavengers, reacting rapidly with . OH, whereas cysteamine acts preferentially as a chelator of iron and in this way prevents the formation of . OH. In regard to superoxide anion radicals, both captopril and cysteamine in vitro demonstrate unsatisfactory scavenging activity, and mercapoethanol does not scavenge these radicals in concentrations up to 10 mM. Although the beneficial role of the compounds we tested result from their immediate antioxidant properties, the chelator and scavenger activity of these thiols should not be neglected and should be taken into consideration as an overall therapeutic and experimental treatment.
